Waverton Investment Management Ltd Purchases 73,223 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Waverton Investment Management Ltd increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 11.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 699,730 shares of the company's stock after buying an additional 73,223 shares during the quarter. GE HealthCare Technologies comprises 0.9% of Waverton Investment Management Ltd's portfolio, making the stock its 27th largest holding. Waverton Investment Management Ltd owned about 0.15% of GE HealthCare Technologies worth $56,447,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Haverford Trust Co raised its stake in shares of GE HealthCare Technologies by 2.4% during the fourth quarter. Haverford Trust Co now owns 4,896 shares of the company's stock valued at $383,000 after purchasing an additional 115 shares in the last quarter. Intact Investment Management Inc. raised its position in shares of GE HealthCare Technologies by 15.4% during the 4th quarter. Intact Investment Management Inc. now owns 900 shares of the company's stock worth $70,000 after buying an additional 120 shares in the last quarter. LGT Financial Advisors LLC lifted its stake in shares of GE HealthCare Technologies by 46.2% in the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock worth $30,000 after acquiring an additional 123 shares during the period. Integrated Wealth Concepts LLC lifted its stake in shares of GE HealthCare Technologies by 0.7% in the 4th quarter. Integrated Wealth Concepts LLC now owns 17,173 shares of the company's stock worth $1,343,000 after acquiring an additional 126 shares during the period. Finally, Parallel Advisors LLC increased its stake in shares of GE HealthCare Technologies by 1.9% during the fourth quarter. Parallel Advisors LLC now owns 7,135 shares of the company's stock valued at $558,000 after acquiring an additional 135 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 0.4%

Shares of GE HealthCare Technologies stock traded down $0.31 during midday trading on Monday, reaching $74.07. 2,582,561 shares of the company's stock traded hands, compared to its average volume of 3,510,848. The company has a market cap of $33.92 billion, a price-to-earnings ratio of 15.59, a price-to-earnings-growth ratio of 2.51 and a beta of 1.14. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The company's 50 day simple moving average is $70.60 and its 200 day simple moving average is $77.58. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.76 and a current ratio of 0.98.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.91 by $0.10. The company had revenue of $4.78 billion for the quarter, compared to the consensus estimate of $4.66 billion. GE HealthCare Technologies had a return on equity of 24.95% and a net margin of 11.02%. The company's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.90 earnings per share. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies declared that its Board of Directors has approved a share repurchase program on Wednesday, April 30th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the company to repurchase up to 3.1% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

Wall Street Analysts Forecast Growth

GEHC has been the subject of a number of research analyst reports. Morgan Stanley cut their target price on GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. The Goldman Sachs Group dropped their price target on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Wells Fargo & Company lowered their price objective on shares of GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating on the stock in a research note on Thursday, May 1st. Citigroup reduced their target price on shares of GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating for the company in a report on Wednesday, April 30th. Finally, UBS Group upgraded GE HealthCare Technologies from a "sell" rating to a "neutral" rating and cut their price objective for the company from $74.00 to $73.00 in a research report on Monday, May 5th. Three research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $88.27.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.